Sign In
Buy OTIC
$0.0085
+0 (+0%)
At Close: Jul 11, 2023
Otonomy (OTIC) Reports Q2 Loss, Lags Revenue Estimates
11:25pm, Tuesday, 04'th Aug 2020
Otonomy (OTIC) delivered earnings and revenue surprises of -2.78% and -92.06%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Otonomy Reports Second Quarter 2020 Financial Results and Provides Corporate Update
08:22pm, Tuesday, 04'th Aug 2020
* Positive top-line results reported for Phase 1/2 trial of OTO-313 in tinnitus patients * Public offering completed for total gross proceeds of $69.1 million * Results from Phase 3 trial of OTIVI
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
ABIOMED, Inc. (NASDAQ: ABMD)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Annexon Inc (NASDAQ: ANNX)
Atossa...
Otonomy Announces Exclusive License Agreement with Kyorin for Novel Compound in OTO-6XX Hearing Loss Program
11:30am, Monday, 03'rd Aug 2020
Compound has potential to benefit patients with severe hearing lossSAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Otonomy to Report Second Quarter 2020 Financial Results and Provide Corporate Update
08:05pm, Tuesday, 28'th Jul 2020
Webcast and Conference Call to be Held at 5 p.m. EDT on August 4, 2020SAN DIEGO, July 28, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the developme
Stocks To Watch: Big Focus On Big Tech
08:26am, Saturday, 25'th Jul 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results
12:00am, Thursday, 23'rd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 22)
ABIOMED, Inc. (NASDAQ: ABMD)
Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO)
Bio-Rad Laboratories,...
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 16)
AC Immune SA (NASDAQ: ACIU...
Steven Cohen Homes in on Otonomy by Expanding Stake
05:15pm, Wednesday, 15'th Jul 2020
Guru ups bet in biotech focused on ear-related disorders Continue reading...
Otonomy Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
08:01pm, Monday, 13'th Jul 2020
SAN DIEGO, July 13, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the clo
Otonomy (OTIC) Catches Eye: Stock Jumps 9.1%
01:08pm, Monday, 13'th Jul 2020
Otonomy (OTIC) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Otonomy Announces Pricing of $60.1 Million Public Offering
01:00pm, Thursday, 09'th Jul 2020
SAN DIEGO, July 09, 2020 -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced.
Otonomy Announces Proposed Public Offering
01:01am, Thursday, 09'th Jul 2020
SAN DIEGO, July 08, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that it
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
12:00am, Thursday, 09'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 8)
Akero Therapeutics Inc (...
